Publication | Open Access
<i>EGFR</i> Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma
45
Citations
43
References
2019
Year
<i>EGFR</i>-amplified cells are highly sensitive to talazoparib. Our data provide insight into the potential of using <i>EGFR</i> amplification as a selection biomarker for the development of personalized therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1